Featured Research

from universities, journals, and other organizations

Fundamental Finding Yields Insight Into Stem Cells, Cancer; Opens Door To Drug Discovery

Date:
January 12, 2005
Source:
Duke University Medical Center
Summary:
New research by investigators at Duke University Medical Center has provided insight into a fundamental cellular control mechanism that governs tissue regeneration, stem cell renewal and cancer growth. In humans, malfunctions in the pathway have been implicated in skin and brain cancers, as well as certain developmental defects, according to the researchers.

DURHAM, N.C. – New research by investigators at Duke University Medical Center has provided insight into a fundamental cellular control mechanism that governs tissue regeneration, stem cell renewal and cancer growth. In humans, malfunctions in the pathway have been implicated in skin and brain cancers, as well as certain developmental defects, according to the researchers.

The team found that the protein beta-arrestin2, earlier linked to a variety of inhibitory functions, also plays a critical role in activating the so-called hedgehog (Hh) signaling pathway, which plays a central role in early development and normal cell proliferation. When left unchecked, uncontrolled cell growth spurred by the hedgehog pathway can lead to the development of cancerous tumors.

The researchers report their findings in the Dec. 24, 2004, issue of Science. The work was funded by the National Institutes of Health.

"Studies have found a wide breadth of functions for beta-arrestins, but none had revealed a role for these proteins in development," said James B. Duke Professor Marc Caron, Ph.D., a researcher in the department of cell biology, the Duke Institute for Genome Sciences and Policy and senior author of the study. "The involvement of beta-arrestin2 in the hedgehog signaling pathway provides a previously unappreciated paradigm for its role in promoting growth, differentiation, and malignancies."

The finding in zebrafish could lead to new drugs that block the growth of tumors by disrupting the beta-arrestin2 protein's normal function, the researchers said. In other cases, drugs that activate beta-arrestin2 might also drive the proliferation of therapeutic stem cells, they added.

Hh proteins play a central role in cell proliferation and embryonic patterning. In humans, inhibitory mutations in the pathway result in developmental defects such as holoprosencephaly – an often fatal condition characterized by abnormal brain development and facial deformities. In contrast, mutations that spur overactivity of the pathway lead to basal cell carcinoma, the most common form of skin cancer, and medulloblastoma, an aggressive form of brain cancer. About one in five childhood brain tumors are medulloblastomas.

In their experiments, the researchers injected zebrafish embryos with a chemical that specifically blocked the function of beta-arrestin2. Humans and zebrafish, both vertebrates, share fundamental developmental pathways, the researchers said. Zebrafish embryos are an ideal model for study because their transparent embryos allow researchers to easily observe their early development.

The injected embryos, which almost completely lacked the beta-arrestin2 protein, exhibited characteristics earlier linked to defects in the Hh signaling pathway, including curved bodies, underdeveloped heads and abnormal muscle development, the researchers reported. Furthermore, injected embryos exhibited reduced activity of other genes that respond to Hh activity compared to normal embryos, suggesting that loss of beta-arrestin2 blocked their activity, the researchers found. Injection of other substances that activate the Hh pathway restored normal development in embryos lacking beta-arrestin2.

"It appears that beta-arrestin2 is a positive force in Hh signaling in living organisms," Caron said. "The current finding opens up new avenues for study of normal developmental regulation and the manner in which abnormalities in that regulation can lead to cancer. Drugs that disrupt the function of beta-arrestin2 might also offer an alternative approach to cancer therapy."

Another experimental system developed by the researchers -- which includes cells with fluorescently tagged beta-arrestin2 -- might offer a useful tool for identifying drug compounds that either disrupt or promote the protein's activity, said Gregory Fralish, Ph.D., of Duke, co-author of the study. Beta-arrestin2 normally concentrates at the periphery of cells as it binds to activated receptors nestled in the cell membrane, including a component of the Hh pathway known as Smoothened, he explained. Quantifying changes in the amount of fluorescent beta-arrestin2 at the cell surface in the presence of other compounds would therefore identify those that modify Hh pathway activity – compounds of potential therapeutic use.

In a companion paper in the same issue of Science, researchers led by Howard Hughes Medical Institute investigator and James B. Duke Professor Robert Lefkowitz, M.D., also at Duke, demonstrated that beta-arrestin2 does indeed interact with activated Smoothened in cells. That interaction promotes the internalization of activated Smoothened, a finding entirely consistent with the protein's newly recognized role in the signaling pathway, Lefkowitz said.

"The system offers the opportunity to screen for Hh pathway antagonists that might control cancer and, alternatively, for compounds that promote the pathway's activity – a function that might be of use in stimulating the growth of therapeutic stem cells," Fralish said.

Collaborators on the study include lead author Alyson Wilbanks, Margaret Kirby, Larry Barak, and Yin-Xiong Li. Collaborators on the companion study include lead author Wei Chen, Xiurong Ren, Christopher Nelson, Larry Barak, all of Duke; James Chen and Philip Beachy of HHMI and Johns Hopkins University and Frederic de Sauvage from Genentech of South San Francisco.


Story Source:

The above story is based on materials provided by Duke University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Duke University Medical Center. "Fundamental Finding Yields Insight Into Stem Cells, Cancer; Opens Door To Drug Discovery." ScienceDaily. ScienceDaily, 12 January 2005. <www.sciencedaily.com/releases/2005/01/050111174304.htm>.
Duke University Medical Center. (2005, January 12). Fundamental Finding Yields Insight Into Stem Cells, Cancer; Opens Door To Drug Discovery. ScienceDaily. Retrieved April 17, 2014 from www.sciencedaily.com/releases/2005/01/050111174304.htm
Duke University Medical Center. "Fundamental Finding Yields Insight Into Stem Cells, Cancer; Opens Door To Drug Discovery." ScienceDaily. www.sciencedaily.com/releases/2005/01/050111174304.htm (accessed April 17, 2014).

Share This



More Health & Medicine News

Thursday, April 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Obama: 8 Million Healthcare Signups

Obama: 8 Million Healthcare Signups

AP (Apr. 17, 2014) President Barack Obama gave a briefing Thursday announcing 8 million people have signed up under the Affordable Care Act. He blasted continued Republican efforts to repeal the law. (April 17) Video provided by AP
Powered by NewsLook.com
Is Apathy A Sign Of A Shrinking Brain?

Is Apathy A Sign Of A Shrinking Brain?

Newsy (Apr. 17, 2014) A recent study links apathetic feelings to a smaller brain. Researchers say the results indicate a need for apathy screening for at-risk seniors. Video provided by Newsy
Powered by NewsLook.com
Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com
Thousands Of Vials Of SARS Virus Go Missing

Thousands Of Vials Of SARS Virus Go Missing

Newsy (Apr. 16, 2014) A research institute in Paris somehow misplaced more than 2,000 vials of the deadly SARS virus. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins